Clinical Trial Update: 3BNC117 and 10-1074 in HIV Uninfected Adults [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety and pharmacokinetics of two broadly neutralizing HIV antibodies, 3BNC117 and 10-1074, in HIV-uninfected adults; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• 10-1074
• 3BNC117

Snippet

Sponsor: Rockefeller University | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED